Mumps-specific antibody persistence in children aged 3–7 years immunized with two doses of mumps-containing vaccines: A prospective cohort study in Jiangsu Province, China

Mumps reemergence has been reported in developed countries with high levels of two-dose mumps-containing vaccine (MuCV) coverage. The effectiveness of the two-dose MuCV may be compromised by limitations in the persistence of immunity. This prospective cohort study evaluated the persistence of immuni...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jinfang, Li, Mingma, Zhang, Lei, Deng, Xiuying, Hu, Ying, Chen, Qiang, Wang, Zhiguo, Sun, Xiang, Liu, Yuanbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Licensed Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980565/
https://www.ncbi.nlm.nih.gov/pubmed/36653029
http://dx.doi.org/10.1080/21645515.2023.2166758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980565/
https://www.ncbi.nlm.nih.gov/pubmed/36653029
http://dx.doi.org/10.1080/21645515.2023.2166758

Ejemplares similares